Hi [[ session.user.profile.firstName ]]

Beyond Embryonic Stem Cells

With the announcement of a pending change in Federal rules governing stem cell research, Embryonic Stem Cells have dominated the news in recent days. However, there are other methods of producing pluripotent stem cells that provide exciting alternatives and opportunities to advance human therapy th
With the announcement of a pending change in Federal rules governing stem cell research, Embryonic Stem Cells have dominated the news in recent days. However, there are other methods of producing pluripotent stem cells that provide exciting alternatives and opportunities to advance human therapy that go beyond what is likely from embryonic stem cells. These include Parthenogenic Stem Cells (made without the use or destruction of human embryos) that may offer a solution to the problem of immune rejection; Induced Pluripotent Stem cells made from skin or other tissue, including possibly tissue from the patient; and Somatic Cell Nuclear Transfer, which has been largely forgotten, but offers very interesting possibilities. This presentation will discuss these and their various advantages and disadvantages as compared to each other and embryonic stem cells.
Recorded May 12 2009 45 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Kenneth Aldrich, CEO, International Stem Cell Corporation
Presentation preview: Beyond Embryonic Stem Cells

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Beyond Embryonic Stem Cells
  • Live at: May 12 2009 4:00 pm
  • Presented by: Kenneth Aldrich, CEO, International Stem Cell Corporation
  • From:
Your email has been sent.
or close
You must be logged in to email this